• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study.

作者信息

Bourmayan C, Razavi A, Fournier C, Dussaule J C, Baragan J, Gerbaux A, Gay J

出版信息

Am Heart J. 1985 Jun;109(6):1311-6. doi: 10.1016/0002-8703(85)90357-6.

DOI:10.1016/0002-8703(85)90357-6
PMID:4039882
Abstract

Many authors have shown that hypertrophic cardiomyopathy (HCM) is often associated with diastolic abnormalities. The purpose of this study was to determine the effect of propranolol on left ventricular isovolumic relaxation time (IVRT) measured by echocardiography in 20 patients with hypertrophic cardiomyopathy under basal conditions and under increasing doses of propranolol (160 mg, 320 mg, and 480 mg per day) and in two control groups, 10 patients with aortic stenosis, and 10 normal subjects. IVRT was less than 50 msec in all normal subjects, while it was always above this limit in aortic stenosis (77 msec +/- 8, p less than 0.001), and in hypertrophic cardiomyopathy (94 msec +/- 19, p less than 0.001), with also a significant difference between these two last groups (p less than 0.01). Under increasing doses of propranolol, relaxation time often shortens gradually until 50 msec or less. These results show an improvement in left ventricular relaxation dependent on the propranolol dosage and often a normalization at high dosages.

摘要

相似文献

1
Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study.
Am Heart J. 1985 Jun;109(6):1311-6. doi: 10.1016/0002-8703(85)90357-6.
2
[Effects of beta-blockers and Ca antagonists on diastolic function of the hypertrophied left ventricle: an echocardiographic study].[β受体阻滞剂和钙拮抗剂对肥厚左心室舒张功能的影响:一项超声心动图研究]
J Cardiogr. 1982 Dec;12(4):939-52.
3
Diastolic function in hypertrophic cardiomyopathy: effects of propranolol and verapamil on diastolic stiffness.
Eur Heart J. 1983 Nov;4 Suppl F:47-56. doi: 10.1093/eurheartj/4.suppl_f.47.
4
Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy.维拉帕米对肥厚型心肌病患者左心室收缩功能和舒张充盈的影响。
Circulation. 1981 Oct;64(4):787-96. doi: 10.1161/01.cir.64.4.787.
5
Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.硝苯地平对肥厚型心肌病患者左心室舒张异常特性的改善作用
Circulation. 1982 Mar;65(3):499-507. doi: 10.1161/01.cir.65.3.499.
6
Pressure-derived indices of left ventricular isovolumic relaxation in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者左心室等容舒张期压力衍生指标
Br Heart J. 1983 Mar;49(3):259-67. doi: 10.1136/hrt.49.3.259.
7
Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
J Am Coll Cardiol. 1983 Nov;2(5):879-86. doi: 10.1016/s0735-1097(83)80235-6.
8
Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?
Circulation. 1986 Sep;74(3):530-43. doi: 10.1161/01.cir.74.3.530.
9
[Time constant of the left ventricular pressure fall, and onset and rate of expansion of the left ventricular segment in hypertrophic cardiomyopathy].[肥厚型心肌病患者左心室压力下降的时间常数以及左心室节段的起始扩张和扩张速率]
J Cardiol. 1987 Sep;17(3):489-95.
10
Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy.
Circulation. 1985 Aug;72(2):310-6. doi: 10.1161/01.cir.72.2.310.

引用本文的文献

1
Current and emerging medical and surgical therapy in hypertrophic cardiomyopathy.肥厚型心肌病的当前及新兴药物与手术治疗
J Cardiovasc Imaging. 2025 Sep 24;33(1):13. doi: 10.1186/s44348-025-00050-9.
2
Effect of metoprolol in hypertrophic obstructive cardiomyopathy patients after alcohol septal ablation.美托洛尔对肥厚性梗阻性心肌病患者酒精间隔消融术后的影响。
Int J Cardiol Heart Vasc. 2023 Dec 2;49:101317. doi: 10.1016/j.ijcha.2023.101317. eCollection 2023 Dec.
3
Neonatal cardiac hypertrophy: the role of hyperinsulinism-a review of literature.
新生儿心脏肥大:高胰岛素血症的作用——文献综述。
Eur J Pediatr. 2020 Jan;179(1):39-50. doi: 10.1007/s00431-019-03521-6. Epub 2019 Dec 16.
4
Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy.影响瑞典西部梗阻性肥厚型心肌病患者长期心力衰竭死亡率的因素:β受体阻滞剂治疗可能存在剂量相关性保护作用。
Open Heart. 2019 Jun 27;6(1):e000963. doi: 10.1136/openhrt-2018-000963. eCollection 2019.
5
Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation.对一名因MYH7基因突变导致家族性肥厚型心肌病的胎儿进行宫内治疗。
Pediatr Cardiol. 2015 Dec;36(8):1774-7. doi: 10.1007/s00246-015-1250-1. Epub 2015 Sep 4.
6
Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies.β受体阻滞剂在小儿肥厚型心肌病中的应用
Rev Recent Clin Trials. 2014;9(2):82-5. doi: 10.2174/1574887109666140908125158.
7
Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.生活方式改变和高剂量β受体阻滞剂治疗对肥厚型心肌病儿童、青少年及年轻成人运动能力的影响。
Cardiol Young. 2015 Mar;25(3):501-10. doi: 10.1017/S1047951114000237. Epub 2014 Mar 10.
8
Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.2013年肥厚型心肌病:当前推测与未来展望
World J Cardiol. 2014 Feb 26;6(2):26-37. doi: 10.4330/wjc.v6.i2.26.
9
Effect of propranolol upon protein and proteolytic synthesis activity in hypertrophic myocardium.普萘洛尔对肥厚心肌中蛋白质及蛋白水解合成活性的影响。
Basic Res Cardiol. 1988 Jan-Feb;83(1):43-7. doi: 10.1007/BF01907103.